Regulatory Blog

28 September 2020

The first NHS prescription for a child’s cannabis medicine - is the case of Billy Caldwell an outlier or the start of a trend?

For the first time, the NHS has agreed to fund a prescription for an unlicensed cannabis-based medicine product (CBMP) for a child. On 14 September 2020, the NHS announced its decision to fund the treatment of Billy Caldwell who is severely epileptic. This decision comes nearly two years after the law changed on 1 November 2018, allowing for CBMP’s to be prescribed by specialists for patients who cannot be helped by other available licensed drugs.

Shannett Thompson

25 September 2020

When does a regulator pay costs? The Court of Appeal has spoken

CMA v Flynn Pharma Ltd, Flynn Pharma Holdings Ltd, Pfizer Inc and Pfizer Ltd [2020] EWCA Civ 617 

Shannett Thompson

21 September 2020

COVID-19: The Care Quality Commission announces resumption of routine inspections

In March 2020, the Care Quality Commission (CQC) announced it would temporarily suspend its routine inspections of care homes to allow care home providers to focus on infection containment at what was the peak of the first wave of infection during the COVID-19 pandemic.

Sophie Bolzonello

8 September 2020

The first crucial steps: how Universities should respond to allegations of misconduct

University providers owe a duty of care towards staff members and students; this duty takes on particular significance during a disciplinary process and it is essential that Universities provide appropriate and relevant information and support to all parties involved in allegations of misconduct.

Christina Orthodoxou

1 September 2020

Getting it right from the start: University policies for dealing with non-academic misconduct complaints

What happens when a complaint is made to a University about the conduct of a student or a member of academic staff?  What should the procedures for the resolution of these complaints look like and how can all parties be reassured that such allegations will be resolved fairly? 

Julie Norris

Skip to content Home About Us Insights Services Contact Accessibility